These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34370801)

  • 1. Systematic investigation of mouse models of Parkinson's disease by transcriptome mapping on a brain-specific genome-scale metabolic network.
    Abdik E; Çakır T
    Mol Omics; 2021 Aug; 17(4):492-502. PubMed ID: 34370801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome-based biomarker prediction for Parkinson's disease using genome-scale metabolic modeling.
    Abdik E; Çakır T
    Sci Rep; 2024 Jan; 14(1):585. PubMed ID: 38182712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Scale Brain Metabolic Networks as Scaffolds for the Systems Biology of Neurodegenerative Diseases: Mapping Metabolic Alterations.
    Özcan E; Çakır T
    Adv Neurobiol; 2018; 21():195-217. PubMed ID: 30334223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic Profiling of Circular RNA in Different Brain Regions of Parkinson's Disease in a Mouse Model.
    Jia E; Zhou Y; Liu Z; Wang L; Ouyang T; Pan M; Bai Y; Ge Q
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network.
    Sertbaş M; Ulgen K; Cakır T
    FEBS Open Bio; 2014; 4():542-53. PubMed ID: 25061554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nervonic acid improves liver inflammation in a mouse model of Parkinson's disease by inhibiting proinflammatory signaling pathways and regulating metabolic pathways.
    Wang X; Liang T; Mao Y; Li Z; Li X; Zhu X; Cao F; Zhang J
    Phytomedicine; 2023 Aug; 117():154911. PubMed ID: 37276724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-wide transcriptome-based metabolic alterations in Parkinson's disease: human inter-region and human-experimental model correlations.
    Odongo R; Bellur O; Abdik E; Çakır T
    Mol Omics; 2023 Aug; 19(7):522-537. PubMed ID: 36928892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-scale metabolic network reconstruction of model animals as a platform for translational research.
    Wang H; Robinson JL; Kocabas P; Gustafsson J; Anton M; Cholley PE; Huang S; Gobom J; Svensson T; Uhlen M; Zetterberg H; Nielsen J
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34282017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iMM1865: A New Reconstruction of Mouse Genome-Scale Metabolic Model.
    Khodaee S; Asgari Y; Totonchi M; Karimi-Jafari MH
    Sci Rep; 2020 Apr; 10(1):6177. PubMed ID: 32277147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pathway and network analysis of brain transcriptome changes during adult aging and in Parkinson's disease.
    Glaab E; Schneider R
    Neurobiol Dis; 2015 Feb; 74():1-13. PubMed ID: 25447234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-Scale Characterization of Toxicity-Induced Metabolic Alterations in Primary Hepatocytes.
    Rawls KD; Blais EM; Dougherty BV; Vinnakota KC; Pannala VR; Wallqvist A; Kolling GL; Papin JA
    Toxicol Sci; 2019 Dec; 172(2):279-291. PubMed ID: 31501904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational prediction of changes in brain metabolic fluxes during Parkinson's disease from mRNA expression.
    Supandi F; van Beek JHGM
    PLoS One; 2018; 13(9):e0203687. PubMed ID: 30208076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-scale modeling and in silico analysis of mouse cell metabolic network.
    Selvarasu S; Karimi IA; Ghim GH; Lee DY
    Mol Biosyst; 2010 Jan; 6(1):152-61. PubMed ID: 20024077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ModelExplorer - software for visual inspection and inconsistency correction of genome-scale metabolic reconstructions.
    Martyushenko N; Almaas E
    BMC Bioinformatics; 2019 Jan; 20(1):56. PubMed ID: 30691403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The landscape of multiscale transcriptomic networks and key regulators in Parkinson's disease.
    Wang Q; Zhang Y; Wang M; Song WM; Shen Q; McKenzie A; Choi I; Zhou X; Pan PY; Yue Z; Zhang B
    Nat Commun; 2019 Nov; 10(1):5234. PubMed ID: 31748532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic profiling of differentially expressed genes and related pathways in different brain regions in Parkinson's disease.
    Jia E; Pan M; Liu Z; Zhou Y; Zhao X; Dong J; Bai Y; Ge Q
    Neurosci Lett; 2020 Jul; 732():135074. PubMed ID: 32446776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlocking Human Brain Metabolism by Genome-Scale and Multiomics Metabolic Models: Relevance for Neurology Research, Health, and Disease.
    Sertbas M; Ulgen KO
    OMICS; 2018 Jul; 22(7):455-467. PubMed ID: 30004841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1.
    Sigurdsson MI; Jamshidi N; Steingrimsson E; Thiele I; Palsson BØ
    BMC Syst Biol; 2010 Oct; 4():140. PubMed ID: 20959003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic metabolic analysis of potential target, therapeutic drug, diagnostic method and animal model applicability in three neurodegenerative diseases.
    Li WX; Li GH; Tong X; Yang PP; Huang JF; Xu L; Dai SX
    Aging (Albany NY); 2020 May; 12(10):9882-9914. PubMed ID: 32461378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probabilistic integrative modeling of genome-scale metabolic and regulatory networks in Escherichia coli and Mycobacterium tuberculosis.
    Chandrasekaran S; Price ND
    Proc Natl Acad Sci U S A; 2010 Oct; 107(41):17845-50. PubMed ID: 20876091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.